Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
34,95 USD | +2,64% | +5,97% | +62,41% |
15/05 | Spyre Therapeutics, Inc. Kondigt wijzigingen in de Raad van Bestuur aan | CI |
13/05 | SPYRE THERAPEUTICS, INC. : Wells Fargo Securities herhaalt koopadvies | ZM |
Vakgebied
Aantal werknemers: 30
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Human Enzyme Therapeutics
100,0
%
| 2 | 100,0 % | 1 | 100,0 % | -61,96% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 1 | 100,0 % | -61,96% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cameron Turtle
CEO | Chief Executive Officer | 34 | 22-06-23 |
Scott Burrows
DFI | Director of Finance/CFO | 47 | 01-09-23 |
Brian Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 27/11 |
Chief Tech/Sci/R&D Officer | 56 | 01-02-14 | |
Mira Huyghe
PRN | Corporate Officer/Principal | - | 27/11 |
Deanna Nguyen
PRN | Corporate Officer/Principal | - | 27/11 |
Joshua Friedman
PRN | Corporate Officer/Principal | - | 27/11 |
General Counsel | 41 | 05-09-23 | |
Paul Fehlner
PRN | Corporate Officer/Principal | 61 | 27/11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tomas Kiselak
BRD | Director/Board Member | 37 | 22-06-23 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 27/11 |
Peter Harwin
BRD | Director/Board Member | 38 | 22-06-23 |
Laurie Stelzer
BRD | Director/Board Member | 56 | 27/11 |
Director/Board Member | 34 | 22-06-23 | |
Mark Mckenna
BRD | Director/Board Member | 44 | 01/02 |
Cameron Turtle
CEO | Chief Executive Officer | 34 | 22-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 271 625 | 0 | 0 | 70,36 % |
Aandeel B | 1 | 50 782 384 | 35 728 470 ( 70,36 %) | 0 | |
Aandeel C | 0 | 437 037 | 0 | 0 |
Bedrijfsgegevens
Spyre Therapeutics, Inc.
Building 17 221 Crescent Street
02453, Waltham
+617 651 5940
http://www.aeglea.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+62,41% | 1,77 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |
- Beurs
- Aandelen
- Koers SYRE
- Onderneming Spyre Therapeutics, Inc.